Trial · NCT04709484
Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
NCT04709484, Not applicable, Completed, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey; results first posted 2021-10-20
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis. Trials, record NCT04709484. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04709484
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
- NCT number
- NCT04709484
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 66 participants, actual
- Lead sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Conditions
- Plantar Fasciitis
- Interventions
- USG-guided steroid injection, Palpation-guided steroid injection
- First posted
- 2021-01-14
- Last updated
- 2021-10-20
- Results first posted
- 2021-10-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Severity | day 0 (before intervention) | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. |
| Primary | Pain Severity | 1 month after intervention | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. |
| Primary | Pain Severity | 3 month after intervention | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. |
| Secondary | Foot Function Index | day 0 (before intervention) | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. |
| Secondary | Foot Function Index | 1 month after intervention | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. |
| Secondary | Foot Function Index | 3 month after intervention | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Severity | day 0 (before intervention) | intent to treat population(all participants) | score on a scale | MEAN |
| PRIMARY | Pain Severity | 1 month after intervention | intent to treat population(all participants) | score on a scale | MEAN |
| PRIMARY | Pain Severity | 3 month after intervention | intent to treat population(all participants) | score on a scale | MEAN |
| SECONDARY | Foot Function Index | day 0 (before intervention) | intent to treat population(all participants) | score on a scale | MEAN |
| SECONDARY | Foot Function Index | 1 month after intervention | intent to treat population(all participants) | score on a scale | MEAN |
| SECONDARY | Foot Function Index | 3 month after intervention | intent to treat population(all participants) | score on a scale | MEAN |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pain Severity | USG-guided Steroid Injection Group | 8.50 | Standard Deviation 0.90 | score on a scale | |
| Pain Severity | Palpation-guided Steroid Injection Group | 8.31 | Standard Deviation 0.90 | score on a scale | |
| Pain Severity | USG-guided Steroid Injection Group | 1.50 | Standard Deviation 1.83 | score on a scale | |
| Pain Severity | Palpation-guided Steroid Injection Group | 1.53 | Standard Deviation 2.29 | score on a scale | |
| Pain Severity | USG-guided Steroid Injection Group | 1.44 | Standard Deviation 2.08 | score on a scale | |
| Pain Severity | Palpation-guided Steroid Injection Group | 1.75 | Standard Deviation 2.46 | score on a scale | |
| Foot Function Index | USG-guided Steroid Injection Group | 65.41 | Standard Deviation 12.78 | score on a scale | |
| Foot Function Index | Palpation-guided Steroid Injection Group | 63.78 | Standard Deviation 13.80 | score on a scale | |
| Foot Function Index | USG-guided Steroid Injection Group | 8.06 | Standard Deviation 13.46 | score on a scale | |
| Foot Function Index | Palpation-guided Steroid Injection Group | 7.47 | Standard Deviation 13.66 | score on a scale |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | USG-guided Steroid Injection Group | 34 | |
| Overall Study | STARTED | Palpation-guided Steroid Injection Group | 32 | |
| Overall Study | COMPLETED | USG-guided Steroid Injection Group | 34 | |
| Overall Study | COMPLETED | Palpation-guided Steroid Injection Group | 32 | |
| Overall Study | NOT COMPLETED | USG-guided Steroid Injection Group | 0 | |
| Overall Study | NOT COMPLETED | Palpation-guided Steroid Injection Group | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | USG-guided Steroid Injection Group | 0 | 0 |
| Total, all-cause mortality | Palpation-guided Steroid Injection Group | 0 | 0 |
| Total, other adverse events | USG-guided Steroid Injection Group | 0 | 0 |
| Total, other adverse events | Palpation-guided Steroid Injection Group | 0 | 0 |
| Total, serious adverse events | USG-guided Steroid Injection Group | 0 | 0 |
| Total, serious adverse events | Palpation-guided Steroid Injection Group | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04709484
GET https://conductscience.org/api/trials/v1/NCT04709484/registered